HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 511 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,761,704 | +31.0% | 2,518,700 | -5.9% | 0.44% | +19.8% |
| Q2 2023 | $2,107,645 | +2667805.1% | 2,675,200 | +3047.3% | 0.37% | +2975.0% |
| Q1 2023 | $79 | -72.4% | 85,000 | -92.7% | 0.01% | -58.6% |
| Q4 2022 | $286 | -100.0% | 1,157,800 | +4009.3% | 0.03% | -48.2% |
| Q2 2022 | $1,115,000 | +431.0% | 28,175 | +34.2% | 0.06% | +522.2% |
| Q1 2022 | $210,000 | -11.0% | 21,000 | +7.7% | 0.01% | +50.0% |
| Q4 2021 | $236,000 | +98.3% | 19,500 | +52.3% | 0.01% | +50.0% |
| Q3 2021 | $119,000 | -97.5% | 12,800 | -98.5% | 0.00% | -98.4% |
| Q1 2021 | $4,824,000 | -62.2% | 878,562 | -11.0% | 0.26% | -29.9% |
| Q4 2020 | $12,754,000 | +5042.7% | 986,817 | +4713.7% | 0.37% | +2966.7% |
| Q3 2020 | $248,000 | -84.0% | 20,500 | -93.9% | 0.01% | -85.9% |
| Q2 2020 | $1,551,000 | – | 333,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |